DHA (Docosahexaenoic Acid, algal-derived)

dsm-firmenich AG (Kaiseraugst, Basel-Land, Switzerland; formed by merger of DSM NV Netherlands and Firmenich SA Geneva, completed May 2023; combined revenue ~€12B of which fragrance ~€3-4B) is the world's third-largest fragrance company. Firmenich (private, Geneva; founded 1895 by Philippe Chuit and Martin Naef) was the world's largest private fragrance house and the only major fragrance company to remain independent until the DSM merger. Firmenich's fragrance heritage includes Chanel No. 5 (Firmenich supplies the fragrance compound to Chanel — one of the most carefully guarded commercial relationships in the fragrance industry; the Chanel No. 5 formula is a Firmenich-originated formula from 1921). DSM contributed nutrition, health, and biosciences (vitamins, carotenoids, animal feed enzymes) to the merger. The combined dsm-firmenich operates manufacturing at Geneva (Switzerland), Haverhill (UK), Neuvy-sur-Barangeon (France), and Florham Park (USA). The Firmenich name is retained in the merged entity's fragrance operations branding.

Dutch biobased ingredient company (Euronext: CRBN, HQ Amsterdam); AlgaPrime DHA is Corbion's algal DHA product produced via fermentation of Thraustochytrid microalgae (a different strain from DSM's Schizochytrium). AlgaPrime DHA is positioned as the primary alternative to DSM-Firmenich life'sDHA in infant formula, aquaculture feed, and adult nutrition. Corbion acquired TerraVia's algae assets in 2017 (TerraVia was formerly Solazyme — a biofuels algae company that pivoted to nutrition when fuel economics failed). AlgaPrime DHA is produced at Corbion's fermentation facilities using the same industrial fermentation infrastructure that produces pharmaceutical sodium lactate and polylactic acid (PLA). One Dutch company makes lactic acid for IV bags, PLA for compostable cups, pharmaceutical sodium lactate for Ringer's solution, AND algal DHA for infant formula — all from microorganism fermentation.

German specialty chemicals company (XETRA: EVK, HQ Essen; ~€15B revenue); Health Care division produces specialty lipids and fatty acids including algal omega-3s. Evonik and DSM jointly created VERAMARIS (Essen Germany; 50-50 JV) — which produces high-EPA/DHA algal oil for aquaculture feed (salmon farming) using the same Schizochytrium fermentation platform as life'sDHA but specifically targeting salmon feed markets where fish oil (traditionally sourced from Peruvian anchovies) is being replaced by algal omega-3. VERAMARIS is not directly an infant formula DHA supplier, but represents Evonik's capability in the algal omega-3 space. Evonik also produces the amino acids (methionine, threonine) used in animal feed and the lipid excipients used in mRNA vaccine formulation (Evonik supplied lipid nanoparticle components for Pfizer/BioNTech COVID vaccines).